A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects

Clinical trial NCT00567255 · COMPLETED

Trial details

NCT number: NCT00567255
Sponsor: Orexigen Therapeutics, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2007-12-01
Primary completion: 2009-06-01
Enrollment: 1496

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.